YmAbs Therapeutics (YMAB)
(Delayed Data from NSDQ)
$6.33 USD
-0.17 (-2.62%)
Updated Jan 14, 2025 04:00 PM ET
After-Market: $6.31 -0.02 (-0.32%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth A Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 3/6/25 |
---|---|
Current Quarter | -0.13 |
EPS Last Quarter | -0.16 |
Last EPS Surprise | -14.29% |
ABR | 1.47 |
Earnings ESP
|
12.00% |
---|---|
Current Year | -0.64 |
Next Year | -0.52 |
EPS (TTM) | -0.54 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 27.04M | 24.61M | 90.50M | 105.64M |
# of Estimates | 6 | 4 | 1 | 6 |
High Estimate | 28.00M | 28.80M | 90.50M | 118.43M |
Low Estimate | 25.81M | 22.42M | 90.50M | 97.00M |
Year ago Sales | 23.36M | 19.93M | 84.82M | 90.50M |
Year over Year Growth Est. | 15.73% | 23.46% | 6.70% | 16.73% |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.13 | -0.15 | -0.64 | -0.52 |
# of Estimates | 6 | 4 | 6 | 7 |
Most Recent Consensus | -0.11 | -0.13 | -0.55 | -0.44 |
High Estimate | -0.04 | -0.04 | -0.56 | -0.23 |
Low Estimate | -0.25 | -0.22 | -0.75 | -0.94 |
Year ago EPS | -0.02 | -0.15 | -0.49 | -0.64 |
Year over Year Growth Est. | -550.00% | 0.00% | -30.61% | 18.34% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 0 | 1 |
Up Last 30 Days | 1 | 1 | 0 | 2 |
Up Last 60 Days | 1 | 1 | 0 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.13 | -0.15 | -0.64 | -0.52 |
7 Days Ago | -0.13 | -0.16 | -0.64 | -0.54 |
30 Days Ago | -0.13 | -0.16 | -0.64 | -0.56 |
60 Days Ago | -0.12 | -0.09 | -0.63 | -0.41 |
90 Days Ago | -0.10 | -0.11 | -0.59 | -0.41 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.11 | -0.13 | -0.64 | -0.39 |
Zacks Consensus Estimate | -0.13 | -0.15 | -0.64 | -0.52 |
Earnings ESP | 12.00% | 14.75% | 0.00% | 26.57% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.16 | -0.21 | -0.15 | -0.02 | NA |
Estimate | -0.14 | -0.13 | -0.12 | -0.19 | NA |
Difference | -0.02 | -0.08 | -0.03 | 0.17 | 0.01 |
Surprise | -14.29% | -61.54% | -25.00% | 89.47% | -2.84% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more